Santen Pharmaceutical Co Ltd
TSE:4536
Santen Pharmaceutical Co Ltd
TSE:4536
Price:
1 891
JPY
0.83%
Market Cap:
¥609.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Santen Pharmaceutical Co Ltd
TSE:4536
|
JP |
|
B
|
Blue Innovation Co Ltd
TSE:5597
|
JP |
|
National Health Investors Inc
NYSE:NHI
|
US |
|
Gongniu Group Co Ltd
SSE:603195
|
CN |
|
Alpek SAB de CV
BMV:ALPEKA
|
MX |
|
SML Mahindra Limited
NSE:SMLMAH
|
IN |
|
Vista Outdoor Inc
NYSE:VSTO
|
US |
|
S
|
Scotgold Resources Ltd
LSE:SGZ
|
AU |
|
DLC Asia Ltd
HKEX:8210
|
HK |
Multiples-Based Value
The Multiples-Based Value of one
Santen Pharmaceutical Co Ltd
stock under the Base Case scenario is
hidden
JPY.
Compared to the current market price of 1 891 JPY,
Santen Pharmaceutical Co Ltd
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Santen Pharmaceutical Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Santen Pharmaceutical Co Ltd Competitors
Santen Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| JP |
|
Santen Pharmaceutical Co Ltd
TSE:4536
|
608.3B JPY | 2.1 | 19.9 | 10 | 14.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
875.9B USD | 13.4 | 42.4 | 28.6 | 30.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
580.2B USD | 6.2 | 21.6 | 15 | 18.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP | 5.3 | 30.4 | 16.8 | 23.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD | 4.6 | 16.4 | 10.2 | 12.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF | 5.2 | 20.9 | 12.9 | 16.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
158.2B USD | 2.5 | 20.4 | 7.8 | 10.4 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.4B USD | 2.5 | 16.9 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
